|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/568 | (2006.01) |
| A61K 9/4858 | (2013.01) | ||
| A61P 5/24 | (2006.01) | ||
| A61K 31/568 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 5/24 | (2018.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 3548037 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17876230.8 |
| Date of filing the European patent application | 2017-11-30 | |
| (97) | Date of publication of the European application | 2019-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/064083 |
| Date | 2017-11-30 |
| (87) | Number | WO 2018/102618 |
| Date | 2018-06-07 |
| (30) | Number | Date | Country code |
| 201662428167 P | 2016-11-30 | US | |
| 201662428317 P | 2016-11-30 | US |
| (72) |
CHIDAMBARAM, Nachiappan , US
NACHAEGARI, Satish Kumar , US
PATEL, Mahesh V. , US
KIM, Kilyoung , US
|
| (73) |
Lipocine Inc. ,
675 Arapeen Drive Suite 202, Salt Lake City, UT 84108,
US
|
| (54) | ORAL TESTOSTERONE TRIDECANOATE THERAPY |
| ORAL TESTOSTERONE TRIDECANOATE THERAPY |